PULSE BIOSCIENCES, INC. — Director's Dealing 2017

Feb 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-02-09

Reporting Person: Zanganeh Maky (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-09	Stock Option (right to buy)	$7.55	A	45000	Acquired	2027-02-09	Common Stock (45000)	Direct

Footnotes

F1: The shares subject to the option will vest in equal monthly installments over three years commencing on the date of grant subject to the Reporting Person's continued service to the Company.